Co-administration of COVID-19 and influenza vaccines

Didierlaurent, Arnaud; Lambert, Paul Henri

doi:10.1016/j.cmi.2023.02.003

Scientific article

Comment

English

Co-administration of COVID-19 and influenza vaccines

ContributorsDidierlaurent, Arnaud

; Lambert, Paul Henri

Published inClinical microbiology and infection, vol. 29, no. 5, p. 558-559

Publication date2023-05

Abstract

Comment on : Radner H, Sieghart D, Jorda A, Fedrizzi C, Hasenöhrl T, Zdravkovic A, Redlberger-Fritz M, Puchammer-Stoeckl E, Anderle K, Bergmann F, Firbas C, Jordakieva G, Wagner B, Haslacher H, Perkmann T, Heinz LX, Bonelli M, Crevenna R, Aletaha D, Zeitlinger M. Reduced immunogenicity of BNT162b2 booster vaccination in combination with a tetravalent influenza vaccination: results of a prospective cohort study in 838 health workers. Clin Microbiol Infect. 2023 May;29(5):635-641. doi: 10.1016/j.cmi.2022.12.008. PMID: 36509374.

Keywords

COVID-19
Co-administration
Immunogenicity
Influenza
Vaccine

Affiliation entities

Faculté de médecine / Section de médecine fondamentale / Département de pathologie et immunologie

Research groups

Laboratoire d'immunologie vaccinale humaine (1025)

Citation (ISO format)

DIDIERLAURENT, Arnaud, LAMBERT, Paul Henri. Co-administration of COVID-19 and influenza vaccines. In: Clinical microbiology and infection, 2023, vol. 29, n° 5, p. 558–559. doi: 10.1016/j.cmi.2023.02.003

Article (Published version)

OA OTHER

Identifiers

PID : unige:180612
DOI : 10.1016/j.cmi.2023.02.003
PMID : 36773770

Additional URL for this publicationhttps://linkinghub.elsevier.com/retrieve/pii/S1198743X23000563

Journal ISSN1198-743X

51views

73downloads

Creation07/10/2024 15:57:37

First validation08/10/2024 12:23:36

Update time30/10/2024 13:17:00

Status update30/10/2024 13:17:00

Last indexation30/10/2024 13:19:01

Archive ouverte UNIGE

Co-administration of COVID-19 and influenza vaccines

Technical informations